Susanne Michen

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Epigenetic editing balances TCR suppression and persistence in CAR T cells.

Epigenetic editing balances TCR suppression and persistence in CAR T cells.

Journal: Molecular therapy. Advances

Published: September 03, 2025

CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation.

CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation.

Journal: Journal for immunotherapy of cancer

Published: December 24, 2023

Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas.

Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas.

Journal: International journal of molecular sciences

Published: December 15, 2022

A new approach for clinical translation of infrared spectroscopy: exploitation of the signature of glioblastoma for general brain tumor recognition.

A new approach for clinical translation of infrared spectroscopy: exploitation of the signature of glioblastoma for general brain tumor recognition.

Journal: Journal of neuro-oncology

Published: November 02, 2022

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme.

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme.

Journal: International journal of molecular sciences

Published: April 28, 2022

Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases.

Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases.

Journal: Oncogene

Published: November 03, 2021

Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors.

Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors.

Journal: Pharmaceutics

Published: April 14, 2021

Multivalent Protein-Loaded pH-Stable Polymersomes: First Step toward Protein Targeted Therapeutics.

Multivalent Protein-Loaded pH-Stable Polymersomes: First Step toward Protein Targeted Therapeutics.

Journal: Macromolecular bioscience

Published: March 14, 2021

Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self.

Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self.

Journal: Cytotherapy

Published: October 04, 2019

Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis.

Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis.

Journal: Scientific reports

Published: June 28, 2018

Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells.

Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells.

Journal: BMC cancer

Published: July 04, 2017

A Poly(Propyleneimine) Dendrimer-Based Polyplex-System for Single-Chain Antibody-Mediated Targeted Delivery and Cellular Uptake of SiRNA.

A Poly(Propyleneimine) Dendrimer-Based Polyplex-System for Single-Chain Antibody-Mediated Targeted Delivery and Cellular Uptake of SiRNA.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: January 06, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026